S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes
Journal of Clinical Investigation · 09.01.2024 · 134 (4)
DOI: 10.1172/jci174984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 09.01.2024. Verfasst von Dhaval Dixit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cell Biology and Pathology, New York University Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Lymph Nodes, T-Lymphocytes. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Effective immunity requires a large, diverse naive T cell repertoire circulating among lymphoid organs in search of antigen. Sphingosine 1-phosphate (S1P) and its receptor S1PR1 contribute by both directing T cell migration and supporting T cell survival. Here, we addressed how S1P enables T cell survival and the implications for patients treated with S1PR1 antagonists. We found that S1PR1 limited apoptosis by maintaining the appropriate balance of BCL2 family members via restraint of JNK activity. Interestingly, the same residues of S1PR1 that enable receptor internalization were required to prevent this proapoptotic cascade. Findings in mice were recapitulated in ulcerative colitis patients treated with the S1PR1 antagonist ozanimod, and the loss of naive T cells limited B cell responses. Our findings highlighted an effect of S1PR1 antagonists on the ability to mount immune responses within lymph nodes, beyond their effect on lymph node egress, and suggested both limitations and additional uses of this important class of drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Cell Biology and Pathology, New York University Grossman School of Medicine, New York, New York, USA.
- Department of Medicine and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Oncological Sciences, Department of Dermatology, and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Division of Gastroenterology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- NICHD NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
- Crohn’s and Colitis Foundation
- Leukemia and Lymphoma Society, the Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group
Zitieren
APA
Dixit, D., Hallisey, V. M., Zhu, E. Y., Okuniewska, M., Cadwell, K., Chipuk, J. E., Axelrad, J. E., & Schwab, S. R. (2024). S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes. Journal of Clinical Investigation, 134(4). https://doi.org/10.1172/jci174984
Vancouver
Dixit D, Hallisey VM, Zhu EY, Okuniewska M, Cadwell K, Chipuk JE, et al. S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes. Journal of Clinical Investigation. 2024;134(4). doi:10.1172/jci174984
BibTeX
@article{Dixit2024,
author = {Dixit, Dhaval and Hallisey, Victoria M and Zhu, Ethan Ys and Okuniewska, Martyna and Cadwell, Ken and Chipuk, Jerry E and Axelrad, Jordan E and Schwab, Susan R},
title = {S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {4},
doi = {10.1172/jci174984}
}
EUVIMED